J-STAGE Home  >  Publications - Top  > Bibliographic Information

Bioscience, Biotechnology, and Biochemistry
Vol. 66 (2002) No. 6 P 1213-1217

Language:

http://doi.org/10.1271/bbb.66.1213

Biochemistry & Molecular Biology Regular Papers

  Ovokinin(2-7) (RADHPF), an orally active anti-hypertensive peptide derived from ovalbumin, lowers blood pressure in SHRs at a dose of 10 mg/kg. Attempts were made to potentiate its anti-hypertensive activity by replacing the amino acid residues in [Pro2, Phe3]-ovokinin(2-7), which was previously reported to have 33-fold stronger activity than ovokinin(2-7). The anti-hypertensive activity of [Pro2, Phe3]-ovokinin(2-7) was improved by replacement of the C-terminal Phe residue with Trp. Then, the best amino acid residues at other positions for the anti-hypertensive effect were selected. RPLKPW, the most potent derivative obtained, showed significant anti-hypertensive activities at a dose of 0.1 mg/kg after oral administration in spontaneously hypertensive rats (SHRs). Thus, RPLKPW showed 100-fold more potent anti-hypertensive activity than ovokinin(2-7).

Copyright © 2002 by Japan Society for Bioscience, Biotechnology, and Agrochemistry

Article Tools

Share this Article